Medpace Holdings Inc sell UBS Group AG
Start price
29.07.25
/
50%
€377.20
Target price
29.07.26
€263.00
Performance (%)
-7.11%
Price
24.04.26
€350.40
Summary
This prediction is currently active. With a performance of -7.11%, the SELL prediction for Medpace Holdings Inc by UBS_Group_AG is down slightly. This prediction currently runs until 29.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Medpace Holdings Inc | -20.778% | -20.778% |
| iShares Core DAX® | -1,74 % | 5,98 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % |
| iShares S&P 500 | 0,97 % | 7,62 % |
Comments by UBS_Group_AG for this prediction
In the thread Medpace Holdings Inc diskutieren
Medpace Holdings, Inc. (NASDAQ: MEDP) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $305.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat
Stopped prediction by UBS_Group_AG for Medpace Holdings Inc
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€369.50
15.02.24
15.02.24
€419.64
15.02.25
15.02.25
-11.48%
16.02.25
16.02.25
